8 research outputs found
Recommended from our members
Type A, amicability and injury: A prospective study of air traffic controllers
Recent research has suggested that only a subset of Type A's may be at higher risk for negative health outcomes. The present prospective study of 416 air traffic controllers attempted to determine if a sub-group of Type A's who were disliked by their co-workers had significantly higher risk of injury than liked A's and all Type B's over a 27-month period. Liked B's were not different in terms of injury incidence from their not liked B counterparts (mean annualised rates of injury = 1.9 and 2.1 respectively); not liked Type A's had the highest rates of injuries of any group (8.5) including liked Type A's (3.8). Some psychological instruments were useful in discriminating the Type A not liked group from their liked counterparts and from the Type B's. These discriminating variables were used as covariates to determine if the relationship between being classified a not liked Type A and elevated injury incidence remained. Multiple regression analysis showed that distress from life events and being a not liked Type A remained significantly correlated with later injury (standardised coefficients 0.16 and 0.25 respectively)
Recommended from our members
Relation of hostility to medication adherence, symptom complaints, and blood pressure reduction in a clinical field trial of antihypertensive medication
The impact of hostility was examined in relation to the conduct and results of a clinical field trial. Data were derived from a multi-center randomized double-blind study of the comparative effects of antihypertensive therapy (captopril, methyldopa and propranolol) on the quality of life of 620 hypertensive men. Hostility levels were higher in subjects reporting skipping medication dosages compared to those reporting they always complied with the medication schedule. Reporting of symptoms often associated with antihypertensive drug regimens was positively related to hostility scores throughout the study, even during the blinded placebo period. Persons with high hostility scores showed the greatest decline in blood pressure independent of type of antihypertensive medication. However, there was some limited evidence that hostility levels were significantly reduced by one antihypertensive medication. Overall, the present findings suggest that double-blind pharmacologic clinical trials may benefit from using reliable measures of hostility as covariates in the evaluation of symptom reports and amount of blood pressure reduction